Cytokines, chaperones and neuroinflammatory responses in heroin-related death: What can we learn from different patterns of cellular expression?

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 19831-19845

  Neri, Margherita ^a   Panata, Laura ^b   Bacci, Mauro ^b   Fiore, Carmela ^a   Riezzo, Irene ^a   Turillazzi, Emanuela ^a   Fineschi, Vittorio ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Chaperones; Cyclooxygenase 2; Cytokines; Heat shock proteins; Heroin related death; Neuroinflammatory response; Oxygen regulated protein 150

Indexed keywords

CD15 ANTIGEN; CD68 ANTIBODY; CD68 ANTIGEN; CHAPERONE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 ANTIBODY; CYTOKINE; DIAMORPHINE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 15 ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; OXYGEN REGULATED PROTEIN 150; OXYGEN REGULATED PROTEIN 150 ANTIBODY; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY LABELING; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DENSITOMETRY; FEMALE; GLIA CELL; HEROIN RELATED DEATH; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NERVOUS SYSTEM INFLAMMATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BRAIN; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HEROIN; HUMANS; INFLAMMATION; MALE; MOLECULAR CHAPERONES;

EID: 84885159197     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141019831     Document Type: Article

References (30)

1. Milroy, C.M.; Parai, J.L. The histopathology of drugs of abuse. Histopathology 2011, 59, 579-593.
2. Büttner, A. Review: The neuropathology of drug abuse. Neuropathol. Appl. Neurobiol. 2011, 37, 118-134.
3. Pacifici, R.; Di Carlo, S.; Bacosi, A.; Pichini, S.; Zuccaro, P. Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int. J. Immunopharmacol. 2000, 22, 603-614.
4. Büttner, A.; Weis, S. Neuropathological alterations in drug abusers: The involvement of neurons, glial, and vascular systems. Forensic Sci. Med. Pathol. 2006, 2, 115-126.
5. Büttner, A.; Mall, G.; Penning, R.; Weis, S. The neuropathology of heroin abuse. Forensic Sci. Int. 2000, 113, 435-422.
6. Wang, X.; Loram, L.C.; Ramos, K.; de Jesus, A.J.; Thomas, J.; Cheng, K.; Reddy, A.; Somogyi, A.A.; Hutchinson, M.R.; Watkins, L.R.; et al. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc. Natl. Acad. Sci. USA 2012, 109, 6325-6330.
7. Loram, L.C.; Grace, P.M.; Strand, K.A.; Taylor, F.R.; Ellis, A.; Berkelhammer, D.; Bowlin, M.; Skarda, B.; Maier, S.F.; Watkins, L.R. Prior exposure to repeated morphine potentiates mechanical allodynia induced by peripheral inflammation and neuropathy. Brain Behav. Immun. 2012, 26, 1256-1264.
8. Peterson, P.K.; Molitor, T.W.; Chao, C.C. The opioid-cytokine connection. J. Neuroimmunol. 1998, 83, 63-69.
9. Hutchinson, M.R.; Coats, B.D.; Lewis, S.S.; Zhang, Y.; Sprunger, D.B.; Rezvani, N.; Baker, E.M.; Jekich, B.M.; Wieseler, J.L.; Somogyi, A.A.; et al. Proinflammatory cytokines oppose opioid induced acute and chronic analgesia. Brain Behav. Immun. 2008, 22, 1178-1189.
10. Fitting, S.; Zou, S.; Chen, W.; Vo, P.; Hauser, K.F.; Knapp, P.E. Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: Differential responses to HIV-1 Tat, gp120 and morphine revealed by multiplex analysis. J. Proteome Res. 2010, 9, 1795-1804.
11. Riezzo, I.; Neri, M.; de Stefano, F.; Fulcheri, E.; Ventura, F.; Pomara, C.; Rabozzi, R.; Turillazzi, E.; Fineschi, V. The timing of perinatal hypoxia/ischemia events in term neonates: A retrospective autopsy study. HSPs, ORP-150 and COX-2 are reliable markers to classify acute, perinatal events. Diagn. Pathol. 2010, 5, 49:1-49:12.
12. Allan, S.M.; Rothwell, N.J. Inflammation in central nervous system injury. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2003, 358, 1669-1677.
13. Price, C.J.; Warburton, E.A.; Menon, D.K. Human cellular inflammation in the pathology of acute cerebral ischaemia. J. Neurol. Neurosurg. Psychiatry. 2003, 74, 1476-1484.
14. Ceulemans, A.G.; Zgavc, T.; Kooijman, R.; Hachimi-Idrissi, S.; Sarre, S.; Michotte, Y. The dual role of the neuroinflammatory response after ischemic stroke: Modulatory effects of hypothermia. J. Neuroinflamm. 2010, 7, doi:10.1186/1742-2094-7-74.
15. Schwarz, J.M.; Hutchinson, M.R.; Bilbo, S.D. Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenic programming of anti-inflammatorym IL-10 expression. J. Neurosci. 2011, 31, 17835-17847.
16. Pola, R.; Flex, A.; Gaetani, E.; Flore, R.; Serricchio, M.; Pola, P. Synergistic effect of-174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphismof the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003, 34, 881-885.
17. Neri, M.; Cantatore, S.; Pomara, C.; Riezzo, I.; Bello, S.; Turillazzi, E.; Fineschi, V. Immunohistochemical expression of proinflammatory cytokines IL-1β, IL-6, TNF-α and involvement of COX-2, quantitatively confirmed by Western blot analysis, in Wernicke's encephalopathy. Pathol. Res. Pract. 2011, 207, 652-658.
18. Szelényi, J. Cytokines and the central nervous system. Brain Res. Bull. 2001, 54, 329-338.
19. Szczytkowski, J.L.; Lysle, D.T. Dopamine D1 receptors within the basolateral amygdala mediate heroin-induced conditioned immunomodulation. J. Neuroimmunol. 2010, 226, 38-47.
20. Ikematsu, K.; Tsuda, R.; Kondo, T.; Kondo, H.; Ozawa, K.; Ogawa, S.; Nakasono, I. The expression of "150-kDa oxygen regulated protein (ORP-150)" in human brain and its relationship with duration time until death. Leg. Med. (Tokyo) 2004, 6, 97-101.
21. Truettnera, J.S.; Hu, K.; Liu, C.L.; Dietrich, W.D.; Hu, B. Subcellular stress response and induction of molecular chaperones and folding proteins after transient global ischemia in rats. Brain Res. 2009, 1249, 9-18.
22. Tamatani, M. ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat. Med. 2001, 7, 317-323.
23. Tomimoto, H.; Shibata, M.; Ihara, M.; Akiguchi, I.; Ohtani, R.; Budka, H. A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans. Acta Neuropathol. (Berl.) 2002, 104, 601-607.
24. Oehmichen, M.; Meißner, C.; Reiter, A.; Birkholz, M. Neuropathology in non-human immunodeficiency virus-infected drug addicts: Hypoxic brain damage after chronic intravenous drug abuse. Acta Neuropathol. 1996, 91, 642-646.
25. Andersen, S.N.; Skullerud, K. Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Sci. Int. 1999, 102, 51-59.
26. Weber, M.; Scherf, N.; Kahl, T.; Braumann, U.D.; Scheibe, P.; Kuska, J.P.; Bayer, R.; Büttner, A.; Franke, H. Quantitative analysis of astrogliosis in drug-dependent humans. Brain Res. 2013, 1500, 72-87.
27. Bernstein, H.G.; Stricker, R.; Dobrowolny, H.; Steiner, J.; Bogerts, B.; Trübner, K.; Reiser, G. Nardilysin in human brain diseases: Both friend and foe. Amino Acids 2013, 45, 269-278.
28. Bernstein, H.G.; Trübner, K.; Krebs, P.; Dobrowolny, H.; Bielau, H.; Steiner, J.; Bogerts, B. Increased densities of nitric oxide synthase expressing neurons in the temporal cortex and the hypothalamic paraventricular nucleus of polytoxicomanic heroin overdose victims: Possible implications for heroin neurotoxicity. Acta Histochem. 2013, doi:10.1016/j.acthis.2013.07.006.
29. Tian, X.; Hua, F.; Sandhu, H.K.; Chao, D.; Balboni, G.; Salvadori, S.; He, X.; Xia, Y. Effect of δ-opioid receptor activation on BDNF-TrkB vs. TNF-α in the mouse cortex exposed to prolonged hypoxia. Int. J. Mol. Sci. 2013, 14, 15959-15976.
30. Riezzo, I.; Cerretani, D.; Fiore, C.; Bello, S.; Centini, F.; D'Errico, S.; Fiaschi, A.I.; Giorgi, G.; Neri, M.; Pomara, C.; et al. Enzymatic-nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (Ecstasy) neurotoxicity. J. Neurosci. Res. 2010, 88, 905-916.